3D Cell Culture Global Market

3D Cell Culture Global Market - Forecast to 2028

Publishing Date :	February, 2022
Report Code :	HCBT0106
Price:	Single license $4,950 Site license $6,750 Global license $9,000

Note: The report would be dispatched after confirmation of payment

3D cell culture is an artificial environment that allows biological cells to interact with the environment in a three-dimensional way, similar to cells "in vivo". Cells in a 3D cell culture model are subjected to stimuli and environmental conditions similar to those encountered by the cells of a living organism. The close replication of real-world conditions in 3D cell culture models has made them increasingly becoming popular in variety of applications like tissue engineering, drug discovery, toxicity testing, disease modelling, cancer research, stem cell research and others. The development of advanced scaffold based products (ready to use scaffold based plates, organ specific scaffolds etc), scaffold free products (portable bioreactor, organ on chip etc., and emerging high potential bioprinting technologies will further expands the 3D cell culture applications areas.

The 3D Cell culture global market is expected to grow at a mid teen CAGR from 2021 to 2028. The factors such as increasing funding towards the cell based research, increasing focus towards the application 3D cell culture models in in-vitro testing in drug discovery, toxicity testing due to advantages over 2D cell culture system are driving the 3D cell culture market. Whereas, growing focus towards application of 3D cell culture in the personalized and regenerative medicine and advancement is 3D cell culture technologies such as advanced bioreactors (integrated bioreactor and hand handled bioreactor), magnetic bioprinting or levitation, organ specific scaffolds and integration of AI technologies will provide immense growth opportunities for the 3D cell culture market. However, lack of skilled personnel, complications associated with establishment of 3D cell culture, ethical issues associated with 3D cell culture and stringent process control for handling 3D cell culture expected to hamper the market growth.

The market for 3D cell culture is segmented based on technology, products, end-user and geography. Based on the technology, the market is segmented into scaffold based platforms, scaffold free platforms and bioprinting. Among technologies, Scaffold based platforms is accounted for the highest revenue in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028. Scaffold free platforms is expected to grow at a mid teen CAGR from 2021 to 2028 due to increasing adoption of scaffold free technologies in the development of 3D models such as spheroids and development of advanced scaffold free products such as integrated bioreactor, organ-on chip etc. The scaffold based platforms is further segmented into solid scaffolds, hydrogels and others. Among these, Solid Scaffolds segment is accounted for the highest revenue in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028. Hydrogels is expected to grow at a mid teen CAGR from 2021 due to increasing development of advanced hydrogels. The scaffold free platforms is further segmented into hanging drop method, agitation based method, forced floating and microfluidics. Among these, Forced floating segment is accounted for the highest revenue in 2021 and is expected to grow at a mid teen CAGR from 2021 to 2028. Microfluidics is expected to grow at a high teen CAGR from 2021 to 2028.

Based on the products, the 3D cell culture market is classified into Cells& tissues, Media, Sera and Reagents, Microplates & Others, assay kits, scaffolds and Instruments. Among the products, media, sera and reagents accounted for the highest revenue in 2021 and are expected to grow at a mid teen CAGR from 2021 to 2028 due to an increase in demand for media and reagents in research, and drug discovery applications. Scaffolds segment are expected to grow at a mid teen CAGR from 2021 to 2028 due to development of innovative scaffolds by the companies. Scaffold segment is further sub segmented into natural scaffolds, synthetic scaffolds and hybrid composite. Among these, Natural scaffolds segment is accounted for the highest revenue in 2021 and are expected to grow at a mid teen CAGR from 2021 to 2028. Synthetic Scaffolds segment is expected to grow at a mid teen CAGR from 2021 to 2028.

Based on applications the 3D cell culture market is divided into basic research, toxicity and drug safety screening, tissue engineering, stem cell research, drug discovery, cancer research, and others. Among the applications, cancer research accounted for the highest revenue in 2021 and is expected to grow at a mid teen CAGR from 2021 to 2028. Stem cell research is expected to grow at a mid teen CAGR from 2021 to 2028.

Based on end users, 3D cell culture market is segmented into academic and research institution, biotechnology and pharmaceutical industry, and others. Among these Biotechnology & Pharmaceutical segment is accounted for the highest revenue in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028 due to increasing focus towards the adoption of 3D cell culture in-vitro models in drug discovery and toxicity testing applications and increase in development of new drugs. Other end-users such as CRO’s is expected to grow at a mid teen CAGR from 2021 to 2028 due to increasing focus towards the adoption of 3D cell culture model in drug discovery by the CRO’s.

By geography, the3D cell culture global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K. and Rest of Europe), Asia-Pacific (Japan, China, South Korea, and Rest of APAC) and the Rest of the world (Brazil, Rest of Latin America and the Middle East & Africa). North America accounted for the largest revenue in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028. The factors increase in R&D expenditure, increasing government funding towards the cell based research, increasing drug discovery and development research and growing drug development pipelines, increasing interest towards the personalized medicine and regenerative medicine research and development of innovative 3D cell culture products by the companies for the application in research, drug discovery, and tissue engineering drivers the 3D cell culture market in the region.

Europe is expected to grow at a mid teen CAGR from 2021 to 2028.The factors such as increase in biotech R&D expenditure, presence of major biotech parks, entrepreneurship hubs with the ideal condition for biotech companies, venture capital providers, increasing number biotech companies, government funding for biotech innovative start-ups and cancer research stem cell research, growing drug discovery research by increasing investment in pharmaceutical sector to develop New Product Development (NPD) pipeline, development of advanced 3D cell culture products, entering of new companies with innovative 3D cell culture products and increase in private funding for the development of innovative 3D cell culture products are propelling 3D cell culture market in the region.

The 3D cell culture global market is competitive and all the players in this market are involved in adopting advanced technologies in 3D cell culture to expand their product portfolio and maintain their market shares. The key players in the 3D cell culture global market include Thermo Fisher Scientific (U.S.), Corning (U.S.), Lonza (Switzerland), Merck KGaA (Germany), Insphero (Switzerland), Reprocell (Japan), Greiner-Bio (Austria), Mimetas (Netherlands), Aspect Biosystem (Canada), BICO (Sweden) and 3D systems (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following region:

North America

U.S.
Rest of North America

Europe

Germany
U.K.
France
Rest of Europe

Asia-Pacific

China
Japan
South Korea
Rest of APAC

Rest of the World (RoW)

Brazil
Rest of Latin America
Middle East and Others

1 EXECUTIVE SUMMARY
2 INTRODUCTION

2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY

2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.5 PRIMARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS

3 MARKET ANALYSIS

3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET SEGMENTATION
3.4 FACTORS INFLUENCING MARKET

3.4.1 DRIVERS AND OPPORTUNITIES

3.4.1.1 USE OF 3D CELL CULTURE MODELS IN DRUG DISCOVERY AND DEVELOPMENT AS AN ALTERNATIVE TO ANIMAL TESTING
3.4.1.2 INCREASING FUNDING TOWARDS THE CELL-BASED RESEARCH
3.4.1.3 GROWING FOCUS TOWARDS THE DEVELOPMENT OF PERSONALIZED MEDICINE
3.4.1.4 INCREASING TECHNOLOGICAL ADVANCEMENTS IN 3D CELL CULTURE
3.4.1.5 INCREASING FOCUS ON REGENERATIVE MEDICINE

3.4.2 RESTRAINTS AND THREATS

3.4.2.1 LACK OF SKILLED PERSONNEL
3.4.2.2 LACK OF STANDARDIZATION AND HIGH COST ASSOCIATED WITH 3D CELL CULTURE
3.4.2.3 ETHICAL CHALLENGES ASSOCIATED WITH THE 3D CELL CULTURE
3.4.2.4 STRINGENT PROCESS CONTROLS NEEDED FOR HANDLING 3D CELL CULTURE

3.5 REGULATORY AFFAIRS

3.5.1 UNITED STATES
3.5.2 EUROPE
3.5.3 INDIA
3.5.4 JAPAN

3.6 PORTER’S FIVE FORCE ANALYSIS

3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 BARGAINING POWER OF SUPPLIERS
3.6.4 BARGAINING POWER OF BUYERS
3.6.5 COMPETITIVE RIVALRY

3.7 SUPPLY CHAIN ANALYSIS
3.8 FUNDING SCENARIO
3.9 PATENT ANALYSIS
3.1 DEAL ANALYSIS
3.11 TECHNOLOGICAL ADVANCEMENTS

3.11.1 INTRODUCTION
3.11.2 ADVANCEMENT IN BIOREACTOR SYSTEM
3.11.3 ARTIFICIAL INTELLIGENCE IN 3D CELL CULTURE
3.11.4 MAGNETIC LEVITATION OR MAGNETIC BIOPRINTING
3.11.5 PANDA SYSTEM
3.11.6 DEVELOPMENT OF PATIENT DERIVED ORGANIODS
3.11.7 DEVELOPMENT OF ORGAN SPECIFIC SCAFFOLDS
3.11.8 DEVELOPMENT OF 3D CELL CULTURE WORKSTATIONS
3.11.9 ULTRASONIC STANDING WAVE METHOD

3.12 IMPACT OF COVID-19 ON 3D CELL CULTURE MARKET
3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS

4 3D CELL CULTURE GLOBAL MARKET, BASED ON TECHNOLOGY

4.1 INTRODUCTION
4.2 SCAFFOLD BASED PLATFORMS

4.2.1 SOLID SCAFFOLDS
4.2.2 HYDROGELS
4.2.3 OTHERS

4.3 SCAFFOLD FREE PLATFORMS

4.3.1 HANGING DROP METHOD
4.3.2 FORCED FLOATING
4.3.3 AGITATION BASED METHOD
4.3.4 MICROFLUIDICS

4.4 BIOPRINTING

5 3D CELL CULTURE GLOBAL MARKET, BY PRODUCTS

5.1 INTRODUCTION
5.2 CELLS AND TISSUES
5.3 MEDIA, SERA AND REAGENTS
5.4 MICROPLATES AND OTHERS
5.5 ASSAY KITS
5.6 SCAFFOLDS

5.6.1 NATURAL SCAFFOLDS
5.6.2 SYNTHETIC SCAFFOLDS
5.6.3 HYBRID COMPOSITE

5.7 INSTRUMENTS

6 3D CELL CULTURE GLOBAL MARKET, BY APPLICATION

6.1 INTRODUCTION
6.2 BASIC RESEARCH
6.3 TOXICITY AND DRUG SAFETY SCREENING
6.4 TISSUE ENGINEERING
6.5 STEM CELL RESEARCH
6.6 DRUG DISCOVERY
6.7 CANCER RESEARCH
6.8 OTHERS

7 3D CELL CULTURE GLOBAL MARKET, BY END-USERS

7.1 INTRODUCTION
7.2 ACADEMIC AND RESEARCH INSTITUTES
7.3 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
7.4 OTHERS

8 REGIONAL ANALYSIS

8.1 INTRODUCTION
8.2 NORTH AMERICA

8.2.1 U.S.
8.2.2 REST OF NORTH AMERICA

8.3 EUROPE

8.3.1 GERMANY
8.3.2 U.K.
8.3.3 FRANCE
8.3.4 REST OF EUROPE

8.4 ASIA-PACIFIC

8.4.1 CHINA
8.4.2 JAPAN
8.4.3 SOUTH KOREA
8.4.4 REST OF APAC

8.5 REST OF THE WORLD

8.5.1 BRAZIL
8.5.2 REST OF LATIN AMERICA
8.5.3 MIDDLE EAST AND OTHERS

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 COLLABORATIONS & AGREEMENT
9.3 NEW PRODUCT LAUNCH
9.4 ACQUISITIONS
9.5 OTHERS

10 MAJOR COMPANIES

10.1 3D SYSTEMS

10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS

10.2 ASPECT BIOSYSTEMS

10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS

10.3 BICO(CELLINK)

10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS

10.4 CORNING INCORPORATED

10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS

10.5 GREINER AG

10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS

10.6 INSPHERO AG

10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUISNESS STRATERGY
10.6.6 SWOT ANALYSIS

10.7 LONZA GROUP

10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS

10.8 MERCK KGAA

10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS

10.9 MIMETAS

10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS

10.1 REPROCELL, INC

10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS

10.11 THERMO FISHER SCIENTIFIC, INC

10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCT PORTFOLIO
10.11.4 KEY DEVELOPMENTS
10.11.5 BUSINESS STRATEGY
10.11.6 SWOT ANALYSIS

LIST OF TABLES

TABLE 1 3D CELL CULTURE GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 2 NEW PRODUCT LAUNCH (2020-2021)
TABLE 3 COLLABORATION, PARTENRSHIP AND AGREEMENT (2020-2021)
TABLE 4 3D CELL CULTURE GLOBAL MARKET REVENUE, BASED ON TECHNOLOGY, (2020-2028) ($MN)
TABLE 5 SCAFFOLD BASED PLATFORMS GLOBAL MARKET REVENUE, BASED ON TYPE, (2020-2028) ($MN)
TABLE 6 SCAFFOLD BASED PLATFORMS MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 7 SOLID SCAFFOLDS MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 8 HYDROGELS MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 9 OTHERS MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 10 SCAFFOLD FREE PLATFORMS GLOBAL MARKET REVENUE, BASED ON TYPE, (2020-2028) ($MN)
TABLE 11 SCAFFOLD FREE PLATFORMS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 12 HANGING DROP METHOD GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 13 FORCED FLOATING GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 14 AGITATION BASED METHODS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 15 MICROFLUIDICS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 16 BIOPRINTING GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 17 3D CELL CULTURE GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2020-2028) ($MN)
TABLE 18 CELLS & TISSUES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 19 MEDIA, SERA & REAGENTS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 20 MICROPLATES & OTHERS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 21 ASSAY KITS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 22 SCAFFOLDS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 23 SCAFFOLDS GLOBAL MARKET REVENUE, BASED ON TYPE, (2020-2028) ($MN)
TABLE 24 NATURAL SCAFFOLDS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 25 SYNTHETIC SCAFFOLDS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 26 HYBRID COMPOSITE GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 27 INSTRUMENTS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 28 3D CELL CULTURE GLOBAL MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
TABLE 29 BASIC REASEARCH GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 30 TOXICITY AND DRUG SAFETY SCREENING GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 31 TISSUE ENGINEERING GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 32 STEM CELL RESEARCH GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 33 DRUG DISCOVERY GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 34 CANCER RESEARCH GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 35 OTHERS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 36 3D CELL CULTURE GLOBAL MARKET REVENUE, BASED ON END-USERS, (2020-2028) ($MN)
TABLE 37 ACADEMIC AND RESEARCH INSTITUTES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 38 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 39 OTHERS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 40 3D CELL CULTURE GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
TABLE 41 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY (2020-2028) ($MN)
TABLE 42 NORTH AMERICA SCAFFOLD BASED PLATFORMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
TABLE 43 NORTH AMERICA SCAFFOLD FREE PLATFORMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
TABLE 44 198 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BASED ON PRODUCTS, (2020-2028) ($MN)
TABLE 45 NORTH AMERICA SCAFFOLDS MARKET REVENUE, BY TYPE, (2020-2028) ($MN)
TABLE 46 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
TABLE 47 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BASED ON END-USER, (2020-2028) ($MN)
TABLE 48 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BASED ON COUNTRY (2020-2028) ($MN)
TABLE 49 EUROPE 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY (2020-2028) ($MN)
TABLE 50 EUROPE SCAFFOLD BASED PLATFORMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
TABLE 51 EUROPE SCAFFOLD FREE PLATFORMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
TABLE 52 EUROPE 3D CELL CULTURE MARKET REVENUE, BASED ON PRODUCTS, (2020-2028) ($MN)
TABLE 53 EUROPE SCAFFOLDS MARKET REVENUE, BASED ON TYPE, (2020-2028) ($MN)
TABLE 54 EUROPE 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
TABLE 55 EUROPE 3D CELL CULTURE MARKET REVENUE, BASED ON END-USER, (2020-2028) ($MN)
TABLE 56 EUROPE 3D CELL CULTURE MARKET REVENUE, BASED ON COUNTRY (2020-2028) ($MN)
TABLE 57 APAC 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY (2020-2028) ($MN)
TABLE 58 APAC SCAFFOLD BASED PLATFORMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
TABLE 59 APAC SCAFFOLD FREE PLATFORMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
TABLE 60 APAC 3D CELL CULTURE MARKET REVENUE, BASED ON PRODUCTS, (2020-2028) ($MN)
TABLE 61 APAC SCAFFOLDS MARKET REVENUE, BY TYPE, (2020-2028) ($MN)
TABLE 62 APAC 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
TABLE 63 APAC 3D CELL CULTURE MARKET REVENUE, BASED ON END-USER, (2020-2028) ($MN)
TABLE 64 APAC 3D CELL CULTURE MARKET REVENUE, BASED ON COUNTRY (2020-2028) ($MN)
TABLE 65 ROW 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY (2020-2028) ($MN)
TABLE 66 ROW SCAFFOLD BASED PLATFORMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
TABLE 67 ROW SCAFFOLD FREE PLATFORMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
TABLE 68 ROW 3D CELL CULTURE MARKET REVENUE, BASED ON PRODUCTS, (2020-2028) ($MN)
TABLE 69 ROW SCAFFOLDS MARKET REVENUE, BASED ON TYPE, (2020-2028) ($MN)
TABLE 70 ROW 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
TABLE 71 ROW 3D CELL CULTURE MARKET REVENUE, BASED ON END-USER, (2020-2028) ($MN)
TABLE 72 ROW 3D CELL CULTURE MARKET REVENUE, BASED ON COUNTRY (2020-2028) ($MN)
TABLE 73 COLLABORATIONS & PARTNERSHIPS (2020 – 2021)
TABLE 74 NEW PRODUCT LAUNCH (2020 – 2021)
TABLE 75 ACQUISITION (2020 – 2021)
TABLE 76 3D SYSTEMS: TOTAL REVENUE AND R&D EXPENSES, (2020-2021) (Q3) ($MN)
TABLE 77 3D SYSTEMS: TOTAL REVENUE, BY SEGMENTS, (2020-2021) (Q3) ($MN)
TABLE 78 3D SYSTEMS : TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) (Q3) ($MN)
TABLE 79 BICO: TOTAL REVENUE AND R&D EXPENSES, (2020-2021) (Q3) ($MN)
TABLE 80 BICO: TOTAL REVENUE, BY SEGMENTS, (2020-2021) (Q3) ($MN)
TABLE 81 BICO: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) (Q3) ($MN)
TABLE 82 CORNING INCORPORATED: TOTAL REVENUE AND R&D EXPENSES, (2020-2021) (Q3) ($MN)
TABLE 83 CORNING INCORPORATED: TOTAL REVENUE, BY SEGMENTS, (2020-2021) (Q3) ($MN)
TABLE 84 CORNING INCORPORATED: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) (Q3) ($MN)
TABLE 85 GREINER AG: TOTAL REVENUE AND R&D EXPENSES (2018-2020) ($MN)
TABLE 86 GREINER AG: TOTAL REVENUE, BY SEGMENT, (2018-2020) ($MN)
TABLE 87 GREINER AG: TOTAL REVENUE, BY GEOGRAPHY (2018-2020) ($MN)
TABLE 88 LONZA GROUP: TOTAL REVENUE AND R&D EXPENSES (2020-2021) (Q2) ($MN)
TABLE 89 LONZA GROUP: TOTAL REVENUE, BY SEGMENT, (2020-2021)(Q2) ($MN)
TABLE 90 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2020-2021) (Q3) ($MN)
TABLE 91 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2020-2021) (Q3) ($MN)
TABLE 92 MERCK KGAA: TOTAL REVENUE, BY SUB-SEGMENTS, (2020-2021) (Q3) ($MN)
TABLE 93 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021)(Q3) ($MN)
TABLE 94 THERMO FISHER SCIENTIFIC, INC: TOTAL REVENUE AND R&D EXPENSES (2020-2021)(Q3) ($MN)
TABLE 95 THERMO FISHER SCIENTIFIC, INC: TOTAL REVENUE, BY SEGMENT, (2020-2021) (Q3)($MN)
TABLE 96 THERMO FISHER SCIENTIFIC, INC: TOTAL REVENUE, BY GEOGRAPHY (2020-2021) (Q3)($MN)

LIST OF FIGURES

FIGURE 1 3D CELL CULTURE GLOBAL MARKET SHARE AND REVENUE, BASED ON REGION, (2020-2028) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: 3D CELL CULTURE GLOBAL MARKET
FIGURE 3 3D CELL CULTURE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 3D CELL CULTURE GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 3D CELL CULTURE: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 3D CELL CULTURE GLOBAL MARKET: MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 3D CELL CULTURE GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 3D CELL CULTURE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 3D CELL CULTURE MARKET: PATENT FILING BY MAJOR PLAYERS (2017-2021)
FIGURE 11 3D CELL CULTURE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2021)
FIGURE 12 3D CELL CULTURE GLOBAL MARKET SHARE, BASED ON TECHNOLOGY, (2021 VS 2028) (%)
FIGURE 13 SCAFFOLD BASED PLATFORMS GLOBAL MARKET SHARE, BASED ON TYPE, (2021 VS 2028) (%)
FIGURE 14 SCAFFOLD FREE PLATFORMS GLOBAL MARKET SHARE, BASED ON TYPE, (2021 VS 2028) (%)
FIGURE 15 3D CELL CULTURE GLOBAL MARKET SHARE, BASED ON PRODUCTS, (2021 V/S 2028) (%)
FIGURE 16 SCAFFOLDS GLOBAL MARKET SHARE, BASED ON TYPE, (2021 V/S 2028) (%)
FIGURE 17 3D CELL CULTURE GLOBAL MARKET SHARE, BASED ON APPLICATION, (2021 V/S 2028) (%)
FIGURE 18 DRUG DISCOVERY GLOBAL MARKET SHARE, BY REGION, (2021 V/S 2028) (%)
FIGURE 19 3D CELL CULTURE GLOBAL MARKET SHARE, BASED ON END-USERS, (2021 V/S 2028) (%)
FIGURE 20 3D CELL CULTURE GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN), CAGR (%)
FIGURE 21 3D CELL CULTURE GLOBAL MARKET REVENUE, BY GEOGRAPHY (2021) ($ MN)
FIGURE 22 NORTH AMERICA 3D CELL CULTURE MARKET SHARE, BASED ON TECHNOLOGY (2021 VS 2028) (%)
FIGURE 23 NORTH AMERICA SCAFFOLD BASED PLATFORMS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 24 NORTH AMERICA SCAFFOLD FREE PLATFORMS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 25 NORTH AMERICA 3D CELL CULTURE MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 26 NORTH AMERICA SCAFFOLDS MARKET SHARE, BASED ON TYPE (2021 VS 2028) ($MN)
FIGURE 27 NORTH AMERICA 3D CELL CULTURE MARKET SHARE, BASED ON APPLICATION (2021 VS 2028) (%)
FIGURE 28 NORTH AMERICA 3D CELL CULTURE MARKET SHARE, BASED ON END-USER (2021 VS 2028) (%)
FIGURE 29 NORTH AMERICA 3D CELL CULTURE MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
FIGURE 30 U.S. 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028)($MN)
FIGURE 31 U.S. 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & END-USER (2021 VS 2028)($MN)
FIGURE 32 REST OF NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 33 REST OF NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & END-USER (2021 VS 2028) ($MN)
FIGURE 34 EUROPE 3D CELL CULTURE MARKET SHARE, BASED ON TECHNOLOGY (2021 VS 2028) (%)
FIGURE 35 EUROPE SCAFFOLD BASED PLATFORMS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 36 EUROPE SCAFFOLD FREE PLATFORMS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 37 EUROPE 3D CELL CULTURE MARKET SHARE, BASED ON PRODUCTS (2021 VS 2028) (%)
FIGURE 38 EUROPE SCAFFOLDS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 39 EUROPE 3D CELL CULTURE MARKET SHARE, BASED ON APPLICATION (2021 VS 2028) (%)
FIGURE 40 EUROPE 3D CELL CULTURE MARKET SHARE, BASED ON END-USERS (2021 VS 2028) (%)
FIGURE 41 EUROPE 3D CELL CULTURE MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
FIGURE 42 GERMANY 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 43 GERMANY 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & END-USER (2021 VS 2028) ($MN)
FIGURE 44 U.K. 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 45 U.K. 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & END-USER (2021 VS 2028) ($MN)
FIGURE 46 FRANCE 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 47 FRANCE 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & END-USER (2021 VS 2028) ($MN)
FIGURE 48 REST OF EUROPE 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 49 REST OF EUROPE 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & END-USER (2021 VS 2028) ($MN)
FIGURE 50 APAC 3D CELL CULTURE MARKET SHARE, BASED ON TECHNOLOGY (2021 VS 2028) (%)
FIGURE 51 APAC SCAFFOLD BASED PLATFORMS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 52 APAC SCAFFOLD FREE PLATFORMS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 53 APAC 3D CELL CULTURE MARKET SHARE, BASED ON PRODUCTS (2021 VS 2028) (%)
FIGURE 54 APAC SCAFFOLDS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 55 APAC 3D CELL CULTURE MARKET SHARE, BASED ON APPLICATION (2021 VS 2028) (%)
FIGURE 56 APAC 3D CELL CULTURE MARKET SHARE, BASED ON END-USERS (2021 VS 2028) ($MN)
FIGURE 57 APAC 3D CELL CULTURE MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
FIGURE 58 CHINA 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 59 CHINA 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & END-USER (2021 VS 2028) ($MN)
FIGURE 60 JAPAN 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 61 JAPAN 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & END-USER (2021 VS 2028) ($MN)
FIGURE 62 SOUTH KOREA 3D CELL CULTURE MARKET REVENUE, BASED TECHNOLOGY & BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 63 SOUTH KOREA 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATION AND END-USER (2021 VS 2028) ($MN)
FIGURE 64 REST OF APAC COUNTRIES 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS, (2021 VS 2028) ($MN)
FIGURE 65 REST OF APAC 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & END-USER (2021 VS 2028) ($MN)
FIGURE 66 ROW 3D CELL CULTURE MARKET SHARE, BASED ON TECHNOLOGY (2021 VS 2028) (%)
FIGURE 67 ROW SCAFFOLD BASED PLATFORMS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 68 ROW SCAFFOLD FREE BASED PLATFORMS MARKET SHARE, BASED ON TYPE (2021 VS 2028) (%)
FIGURE 69 ROW 3D CELL CULTURE MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 70 ROW SCAFFOLDS MARKET SHARE, BY TYPE (2021 VS 2028) (%)
FIGURE 71 ROW 3D CELL CULTURE MARKET SHARE, BASED ON APPLICATION (2021 VS 2028) (%)
FIGURE 72 ROW 3D CELL CULTURE MARKET SHARE, BASED ON END-USER (2021 VS 2028) (%)
FIGURE 73 ROW 3D CELL CULTURE MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
FIGURE 74 BRAZIL 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 75 BRAZIL 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & ENDUSER (2021 VS 2028) ($MN)
FIGURE 76 REST OF LATIN AMERICA 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 77 REST OF LATIN AMERICA 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & ENDUSER (2021 VS 2028) ($MN)
FIGURE 78 MIDDLE EAST AND OTHERS 3D CELL CULTURE MARKET REVENUE, BASED ON TECHNOLOGY & PRODUCTS (2021 VS 2028) ($MN)
FIGURE 79 MIDDLE EAST AND OTHERS 3D CELL CULTURE MARKET REVENUE, BASED ON APPLICATIONS & ENDUSER (2021 VS 2028) ($MN)
FIGURE 80 KEY GROWTH STRATEGIES, (2020 – 2021)
FIGURE 81 SWOT: 3D SYSTEMS
FIGURE 82 SWOT: ASPECT BIOSYSTEMS
FIGURE 83 SWOT: BICO
FIGURE 84 SWOT: CORNING INCORPORATED
FIGURE 85 SWOT: GREINER AG
FIGURE 86 SWOT: INSPHERO AG
FIGURE 87 SWOT: LONZA GROUP
FIGURE 88 SWOT: MERCK KGAA
FIGURE 89 SWOT: MIMETAS
FIGURE 90 SWOT: REPROCELL INC.
FIGURE 91 SWOT: THERMO FISHER SCIENTIFIC, INC

LIST OF COMPANIES MENTIONED IN THE REPORT

1 300 Microns GmbH
2 3D BioFibR Inc
3 3D Biotek, LLC
4 3D systems
5 3C-Labs
6 Abcam (BioVision, Inc.)
7 ABLE Corporation
8 Advanced Solutions Life Sciences, LLC
9 AIM Biotech PTE Ltd.
10 amsbio LLC
11 Aspect biosystems
12 Avanticell Science
13 Bellco Glass, Inc
14 BICO (Cellink)
15 BioIVT(Asterand Bioscience)
16 Biolamina AB
17 Bellbrook Labs
18 Bio-Techne Corporation
19 BISS TGT
20 Black Drop Biodrucker GmbH
21 Brinter
22 BRTI Life Sciences
23 Cell Applications, Inc.
24 Cell bio labs
25 Cellaria Inc
26 CellecBiotek AG
27 Cellendes GmbH
28 Cellevate AB
29 CELLnTEC Advanced Cell Systems AG
30 Celprogen
31 CelVivo IVS
32 CollPlant Biotechnologies
33 Corning Incorporated
34 Cyfuse Biomedical KK
35 CN Bio Innovations
36 EBERS Medical Technology SL
37 Ectica Technologies AG
38 Electrospinning Company
39 eNUVIO Inc
40 ESI Bio
41 faCellitate
42 FiberCell Systems Inc
43 Fluicell
44 Genlantis (Gene Therapy Systems, Inc.)
45 GeSiM GmbH
46 Gradientech AB
47 Greiner AG(Greiner Bio-One GmbH)
48 Guangzhou JET Bio-Filtration Co., Ltd.
49 HCS Pharma
50 ibidi GmbH
51 Insphero
52 Inventia Life Science
53 Jellagen
54 JSR Corporation (Organogenix Inc.)
55 Kugelmeiers Ag
56 Lena Biosciences, Inc.
57 Lonza Group
58 Manchester BIOGEL
59 Merck KGaA
60 Microtissues, Inc.
61 Mimetas B.V.
62 Nanofiber Solutions
63 Neuromics Inc
64 Nobel Biocare(Matricel GmbH)
65 Omni Life science
66 Organovo Holdings, Inc
67 PepGel LLC
68 PerkinElmer
69 PHC Corporation
70 Pishon Biomedical
71 Prodizen
72 Promega Corporation
73 PromoCell GmbH
74 RealBio Holdings LLC
75 Regemat 3D S.L
76 Regenhu
77 Regenovo
78 Reprocell (Reinnervate Ltd)
79 Rigenerand
80 Rokit
81 Sartorius Stedim Biotech
82 STEMCELL Technologies Inc.
83 Synthecon, Inc
84 SUN bioscience
85 SynVivo LLC
86 Takara Bio Inc (Clontech)
87 The Well Bioscience Inc.
88 Thermo Fisher Scientific
89 UPM Biomedicals
90 UpNano GmbH
91 Xpect INX

3D Cell Culture Global Market - Forecast to 2028

TABLE OF CONTENTS

LIST OF TABLES

LIST OF FIGURES

LIST OF COMPANIES MENTIONED IN THE REPORT

IQ4I HEALTHCARE REPORTS

about IQ4I

Get in Touch

IQ4I Quality Accredit Certificate

Subscribe to Newsletter